Know Cancer

or
forgot password

Effect of Diacerein on Insulin Secretion in Patients With Type 2 Diabetes Mellitus and Overweight or Obesity


Phase 2
40 Years
60 Years
Not Enrolling
Both
Type 2 Diabetes Mellitus, Overweight, Obesity

Thank you

Trial Information

Effect of Diacerein on Insulin Secretion in Patients With Type 2 Diabetes Mellitus and Overweight or Obesity


Inclusion Criteria:



- Fasting glucose levels between 7.0 and 11.1 mmol/L

- A1C levels between 7 and 9%

- Same residential area and socioeconomic status

- Excessively sedentary or participated in heavy physical activity

- Nonsmokers

- Body weight was stable for at least 3 months before the study

- Blood pressure was <130/80 mm Hg

Exclusion Criteria:

- Personal history of hepatic, renal or coronary artery disease

- Medications known to affect metabolism during the previous 6 months.

Type of Study:

Interventional

Study Design:

Intervention Model: Parallel Assignment, Primary Purpose: Treatment

Outcome Measure:

Fasting insulin concentration

Outcome Time Frame:

2 mo

Safety Issue:

No

Authority:

Mexico: Coordinación de Investigación en Salud

Study ID:

DIADM2-001

NCT ID:

NCT01298882

Start Date:

Completion Date:

Related Keywords:

  • Type 2 Diabetes Mellitus
  • Overweight
  • Obesity
  • Type 2 diabetes mellitus
  • Overweight
  • Obesity
  • Diabetes Mellitus
  • Diabetes Mellitus, Type 2
  • Obesity
  • Overweight

Name

Location